Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: JAMA Oncol. 2016 Apr 1;2(4):508–516. doi: 10.1001/jamaoncol.2015.4935

Figure 1.

Figure 1

A. Overall Survival in all patients by pathologic lymph node status.

Overall survival in all patients stratified by response to primary systemic therapy (PST) in the axilla. Pathologic complete response (pCR) in the axilla is in green, and residual axillary disease is in red. The number of patients at risk is indicated under the x-axis.

B. Relapse Free Survival in all patients by pathologic lymph node status.

Relapse-free survival in all patients stratified by response to PST in the axilla. pCR in the axilla is in green, and residual axillary disease is in red. The number of patients at risk is indicated under the x-axis.